CRMD FY 2016 Earnings — CorMedix Inc. Revenue & Financial Results | Market Cap Arena

CRMDCorMedix Inc.

$518M

FY 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$224,105+6.7% YoY

Gross Profit

-$142,568-63.6% margin

Operating Income

-$25M-11048.8% margin

Net Income

-$25M-10996.5% margin

EPS (Diluted)

$-3.25

Cash Flow

Operating Cash Flow

-$22M

Free Cash Flow

-$22M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$22M

Total Liabilities

$4M

Stockholders' Equity

$18M

Cash & Equivalents

$8M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$224,105	$210,130	+6.7%
Gross Profit	-$142,568	-$108,588	-31.3%
Operating Income	-$25M	-$17M	-48.7%
Net Income	-$25M	-$18M	-35.5%